2.35
+0.07(+3.07%)
Currency In USD
| Previous Close | 2.28 |
| Open | 2.31 |
| Day High | 2.39 |
| Day Low | 2.26 |
| 52-Week High | 980 |
| 52-Week Low | 2.14 |
| Volume | 74,589 |
| Average Volume | 624,062 |
| Market Cap | 2.08M |
| PE | -0.05 |
| EPS | -50.47 |
| Moving Average 50 Days | 4.34 |
| Moving Average 200 Days | 130.95 |
| Change | 0.07 |
RESEND - Northstrive Biosciences Strengthens IP Portfolio with New US Patent Filings for EL-22 and EL-32 Programs Covering Obesity and Animal Health
GlobeNewswire Inc.
Apr 29, 2025 4:15 PM GMT
NEWPORT BEACH, Calif., April 29, 2025 (GLOBE NEWSWIRE) -- Northstrive Biosciences Inc. (“Northstrive”), a subsidiary of PMGC Holdings Inc. (NASDAQ: ELAB) (the “Company,” “PMGC,” “we,” or “our”), today announced the filing of four novel patent appli
Northstrive Biosciences Strengthens IP Portfolio with New US Patent Filings for EL-22 and EL-32 Programs Covering Obesity and Animal Health
GlobeNewswire Inc.
Apr 29, 2025 12:00 PM GMT
NEWPORT BEACH, Calif., April 29, 2025 (GLOBE NEWSWIRE) -- Northstrive Biosciences Inc. (“Northstrive”), a subsidiary of PMGC Holdings Inc. (NASDAQ: ELAB) (the “Company,” “PMGC,” “we,” or “our”), today announced the filing of four novel patent appli
Northstrive Biosciences Co-Founder Featured on Bear Bull Traders Following Announcement of Positive FDA Response Supporting Submission of IND for EL-22 Phase 2 Clinical Trial
GlobeNewswire Inc.
Apr 28, 2025 12:00 PM GMT
NEWPORT BEACH, Calif., April 28, 2025 (GLOBE NEWSWIRE) -- Northstrive Biosciences Inc. (“Northstrive”), a subsidiary of PMGC Holdings Inc. (NASDAQ: ELAB) (the “Company,” “PMGC,” “we,” or “our”), is proud to announce that Co-Founder Deniel Mero was